Interestingly, high expression of GALNT15, one of 3 genes in GRGM-3, was recently shown to predict poor outcomes in gastric cancer patients, and associated with pro-tumorous immune cell infiltration (45). The gene discussed is GALNT15; the disease is gastric cancer.